Ad is loading...
RLNCX
Price
$42.74
Change
-$0.17 (-0.40%)
Updated
Nov 15 closing price
VTSNX
Price
$129.61
Change
-$0.62 (-0.48%)
Updated
Nov 15 closing price
Ad is loading...

RLNCX vs VTSNX

Header iconRLNCX vs VTSNX Comparison
Open Charts RLNCX vs VTSNXBanner chart's image
Russell Inv International Devd Mkts C
Price$42.74
Change-$0.17 (-0.40%)
VolumeN/A
CapitalizationN/A
Vanguard Total Intl Stock Index I
Price$129.61
Change-$0.62 (-0.48%)
VolumeN/A
CapitalizationN/A
RLNCX vs VTSNX Comparison Chart
Loading...
View a ticker or compare two or three
VS
RLNCX vs. VTSNX commentary
Nov 18, 2024

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is RLNCX is a StrongBuy and VTSNX is a Buy.

FUNDAMENTALS
Fundamentals
VTSNX has more cash in the bank: 442B vs. RLNCX (1.02B). VTSNX pays higher dividends than RLNCX: VTSNX (3.29) vs RLNCX (1.06). RLNCX was incepted earlier than VTSNX: RLNCX (16 years) vs VTSNX (14 years). RLNCX is a more actively managed with annual turnover of: 30.00 vs. VTSNX (4.00). RLNCX has a lower initial minimum investment than VTSNX: RLNCX (0) vs VTSNX (5000000). RLNCX (11.03) and VTSNX (10.92) have marching annual gain over last year. RLNCX (16.25) and VTSNX (15.91) have equivalent 5 years return.
RLNCXVTSNXRLNCX / VTSNX
Total Expense RatioN/AN/A-
Annual Report Gross Expense RatioN/AN/A-
Fund Existence16 years14 years-
Gain YTD2.9634.53565%
Front LoadN/AN/A-
Min. Initial Investment05000000-
Min. Initial Investment IRAN/AN/A-
Net Assets1.02B442B0%
Annual Yield % from dividends1.063.2932%
Returns for 1 year11.0310.92101%
Returns for 3 years-2.97-5.8651%
Returns for 5 years16.2515.91102%
Returns for 10 years21.9429.8174%
View a ticker or compare two or three
Ad is loading...
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
STOCK / NAMEPrice $Chg $Chg %
CLSK14.030.05
+0.36%
CleanSpark
BSRR31.33-0.19
-0.60%
Sierra Bancorp
GEHC81.76-1.16
-1.40%
GE HealthCare Technologies
NXTC1.31-0.03
-2.24%
NextCure
RCKT13.98-0.84
-5.67%
Rocket Pharmaceuticals